SPORE in Multiple Myeloma

Alan K Lichtenstein

Sensitivity of multiple myeloma cells to mTOR inhibitors

Multiple myeloma and immunoproliferative diseases

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Wendy Cozen

Genome Wide Admixture Scan for Multiple Myeloma in African Americans

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Multiple myeloma and immunoproliferative diseases

Monica M Bertagnolli

Alliance for Clinical Trials in Oncology Operations Center

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Nikhil C Munshi

Integrative Oncogenomics of Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Genomic Analysis to Gain Insights into Novel and Clinically Relevant Mol

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Robert L Comis

ECOG-ACRIN Operations Center

Multiple myeloma and immunoproliferative diseases

Kenneth C Anderson

Specialized Program of Research Excellence (SPORE) in Multple Myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology